Literature DB >> 2456954

High level of expression in the prostate of a human glandular kallikrein mRNA related to prostate-specific antigen.

P Chapdelaine1, G Paradis, R R Tremblay, J Y Dubé.   

Abstract

Using a synthetic oligonucleotide primer complementary to human prostate-specific antigen mRNA, we found that an additional sequence possibly similar to human glandular kallikrein-1 could be read by a primer-extension sequencing technique. We were able to confirm the identity of that additional sequence with another oligonucleotide primer complementary to a specific region of the human glandular kallikrein-1 mRNA sequence. Northern blot analysis with 2 oligonucleotide probes respectively specific for prostate-specific antigen and human glandular kallikrein-1 mRNAs showed that the length of both mRNAs was similar at 1.5 kb. The level of human glandular kallikrein-1 mRNA relative to that of prostate-specific antigen could be estimated as approx. 10-20%. This study constitutes the first evidence that the human glandular kallikrein-1 gene is expressed at a high level in a human tissue.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2456954     DOI: 10.1016/0014-5793(88)80315-6

Source DB:  PubMed          Journal:  FEBS Lett        ISSN: 0014-5793            Impact factor:   4.124


  10 in total

1.  Immunohistochemical study suggesting a complementary role of kallikreins hK2 and hK3 (prostate-specific antigen) in the functional analysis of human prostate tumors.

Authors:  R R Tremblay; D Deperthes; B Têtu; J Y Dubé
Journal:  Am J Pathol       Date:  1997-02       Impact factor: 4.307

2.  Human prostate specific antigen (PSA) gene: structure and linkage to the kallikrein-like gene, hGK-1.

Authors:  M Digby; X Y Zhang; R I Richards
Journal:  Nucleic Acids Res       Date:  1989-03-11       Impact factor: 16.971

3.  Simultaneous quantification of human glandular kallikrein 2 and prostate-specific antigen mRNAs in peripheral blood from prostate cancer patients.

Authors:  A Ylikoski; M Karp; K Pettersson; H Lilja; T Lövgren
Journal:  J Mol Diagn       Date:  2001-08       Impact factor: 5.568

4.  Rapid elimination kinetics of free PSA or human kallikrein-related peptidase 2 after initiation of gonadotropin-releasing hormone-antagonist treatment of prostate cancer: potential for rapid monitoring of treatment responses.

Authors:  David Ulmert; Andrew J Vickers; Howard I Scher; Charlotte Becker; Peter Iversen; David Frankel; Jens-Kristian Jensen; Tine Kold Olesen; Hans Lilja
Journal:  Clin Chem Lab Med       Date:  2012-11       Impact factor: 3.694

5.  Determination and analysis of antigenic epitopes of prostate specific antigen (PSA) and human glandular kallikrein 2 (hK2) using synthetic peptides and computer modeling.

Authors:  T Piironen; B O Villoutreix; C Becker; K Hollingsworth; M Vihinen; D Bridon; X Qiu; J Rapp; B Dowell; T Lövgren; K Pettersson; H Lilja
Journal:  Protein Sci       Date:  1998-02       Impact factor: 6.725

6.  Evidence for the novel expression of human kallikrein-related peptidase 3, prostate-specific antigen, in the brain.

Authors:  Jeremy G Stone; Raj K Rolston; Masumi Ueda; Hyoung-Gon Lee; Sandy L Richardson; Rudy J Castellani; George Perry; Mark A Smith
Journal:  Int J Clin Exp Pathol       Date:  2008-10-20

7.  Evolution of the rat kallikrein gene family: gene conversion leads to functional diversity.

Authors:  D R Wines; J M Brady; E M Southard; R J MacDonald
Journal:  J Mol Evol       Date:  1991-06       Impact factor: 2.395

Review 8.  Structure, function, and regulation of the enzyme activity of prostate-specific antigen.

Authors:  H Lilja
Journal:  World J Urol       Date:  1993       Impact factor: 4.226

9.  Protein C inhibitor in human body fluids. Seminal plasma is rich in inhibitor antigen deriving from cells throughout the male reproductive system.

Authors:  M Laurell; A Christensson; P A Abrahamsson; J Stenflo; H Lilja
Journal:  J Clin Invest       Date:  1992-04       Impact factor: 14.808

10.  Molecular cloning, purification and in situ localization of human colon kallikrein.

Authors:  L M Chen; G P Richards; L Chao; J Chao
Journal:  Biochem J       Date:  1995-04-15       Impact factor: 3.857

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.